By Manal Abdel Fattah
Researchers in the Sultanate of Oman at the Sultan Qaboos Integrated Center for Cancer Treatment and Research were able to run an advanced genetic test to detect genetic mutations associated with cancer.
The availability of the test within the Sultanate of Oman is an important achievement in the medical field that contributes to determining the most effective treatment for the patient.
Dr. Shuaib bin Abdul Rahman Al-Zadjali from the center’s research laboratories said: The center, represented by the research department, was able to uncover genetic codes to see the components of the DNA of all cells in the body.
Specialized researchers presented a pioneering test that reads the genetic blueprint, which provides hope and innovation in cancer diagnosis and treatment research.
He pointed out that targeted genetic screening was introduced in September 2021, and the research team achieved great progress by implementing a genetic screening that specifically targets cancer genes, and this screening is now fully operational in the Molecular Pathology Laboratory at the Sultan Qaboos Integrated Center for Cancer Treatment and Research, It will help in accurate diagnosis of various types of cancer.
Dr. Shuaib Al-Zadjali added that whole exome sequencing (WES) is the first of its kind in the Sultanate of Oman, and the center’s researchers also took another advanced step by introducing the whole exome sequencing (WES) examination, and this represents an important achievement in the history of medicine in the Sultanate of Oman.
